Recce Pharmaceuticals (ASX:RCE) received a research and development tax rebate of $175,122 from the Canadian government, according to a Monday filing with the Australian bourse.
The pharmaceuticals company expects to receive its tax incentive from the Australian government later this year, per the filing.